Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting

It is not unusual to read about another drug failure in a challenging neurological disease such as multiple sclerosis, Alzheimer’s disease, or Parkinson’s disease. Designing therapeutics with exquisite specificity has been... Read more »